Fasiglifam has been used in trials studying the treatment of Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Diabetes Mellitus, Type 2.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.